SPOR mentioned with Compass and Numi is pretty impressive in this report. This is a buy under $.20. This will be over $.50 by end of january (imo)
https://stockhouse.com/news/press-releases/2020/12/15/psychedelic-drugs-could-create-a-100-billion-investment-opportunity